NEU 0.28% $14.49 neuren pharmaceuticals limited

Positive Results!, page-145

  1. 2,170 Posts.
    lightbulb Created with Sketch. 572
    Acadia up again last night off the back of top line positive results in Trof/Rhett phase 3 trial just owing US rights and having to pay us royalties and milestones!

    Yesterday was a big day for us with share price appreciation that was well overdue here, we doubled our market cap to $400m, however Acadia put on $1B added to their market cap.

    What will today bring, will we nudge our previous highs in 2015 & 2018 of $3.60 when were were expecting a Pharma deal TBC.

    We have phase 3 successful top line results now, 65% chance at phase 2 Nz-2591 seriously de risked now!

    Can we start to see share price appreciation to reflect analyst valuations anything like recent Evans Partners $5.40 pre results to $7.70 after positive results?

    Not that I think we would except a TO offer here given we are considerably de risked, but any serious offers now would be starting at $1B for Neu?

 
watchlist Created with Sketch. Add NEU (ASX) to my watchlist
(20min delay)
Last
$14.49
Change
0.040(0.28%)
Mkt cap ! $1.852B
Open High Low Value Volume
$14.50 $14.59 $14.34 $3.228M 223.1K

Buyers (Bids)

No. Vol. Price($)
1 1504 $14.42
 

Sellers (Offers)

Price($) Vol. No.
$14.51 100 1
View Market Depth
Last trade - 16.10pm 31/01/2025 (20 minute delay) ?
NEU (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.